Read + Share
Amedeo Smart
Independent Medical Education
Verweij P, Danaietash P, Flamion B, Menard J, et al. Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension. Hypertension 2020 Feb 17:HYPERTENSIONAHA11914504.PMID: 32063059
Email
LinkedIn
Facebook
Twitter
Privacy Policy